Katharina Hayer

29PUBLICATIONS
101CO-AUTHORS
Innate immunityHaematological tumoursMolecular targetsGenome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Mar 15, 2026
Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells.

Ankita Saini, Leone S Hopkins, Vanida A Serna

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein

|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein

|Jun 17, 2024
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stress.

Dylan F Fingerman, David R O'Leary, Ava R Hansen

|Jan 08, 2024
Locus folding mechanisms determine modes of antigen receptor gene assembly.

Brittney M Allyn, Katharina E Hayer, Clement Oyeniran

Pageof 5

Frequent Collaborators

13 joint publications

Andrei Thomas-Tikhonenko

9 joint publications

Matthew D Weitzman

8 joint publications

Manuel Torres-Diz

6 joint publications

Yoseph Barash